Skip to main content
. 2019 Jul 17;2019(7):CD004307. doi: 10.1002/14651858.CD004307.pub6

Heil 2008.

Methods Study design: RCT; conducted between 2001 and 2003
 Country: USA
 Setting: 4 group obstetric practices and the Women, Infants, and Children (WIC) programme in Burlington, VT
Participants 82 women, gestational age ≤ 20 weeks, smoked at all in the previous 7 days, locally resident, English‐speaking
Mean age 24, Education 11.8 years, mean CPD 18.6; mean gestation 9 weeks
Interventions Abstinence monitoring for first 5 days (Monday to Friday) for all participants, then twice weekly (Mondays, Thursdays) for next 7 weeks, then once a week (Wednesday) for 4 weeks, then every other Wednesday until delivery. In post‐partum period, monitoring increased to every Wednesday for first 4 weeks, then bi‐weekly (every other Wednesday) for next 8 weeks to week 12. Final 24‐week post‐partum testing
 All participants received standard care from their clinic, over and above trial conditions. Also a pamphlet from study staff at baseline, plus another for those not smoking at end of pregnancy. NRT was discouraged for all participants, as it might contaminate testing
Experimental Group (40 women): Contingent vouchers: awarded for proven abstinence during first 5 days. From 2nd week vouchers given for urine cotinine ≤ 80 ng/ml. Vouchers entirely contingent on biochemical specimens, not on self‐report. Values started at USD 6.25, increasing by USD 1.25 per consecutive negative sample, to a maximum of USD 45, where they stayed until a missed visit or a positive test. If reset required, value went back to start point, but 2 valid tests restored to previous level
Control Group (37 women): Vouchers delivered independent of smoking status, at USD 15 per visit antepartum and USD 20 per visit post‐partum. This would average the mean payments earned in the other group
Voucher‐based reinforcement therapy (VBRT) applied until 12 weeks post‐partum
Outcomes Abstinence at end of pregnancy, 12 and 24 weeks post‐partum
Biochemical confirmation by urine cotinine < 80 ng/ml, apart from CO ≤ 6 ppm for first week
Notes New for 2015 update
Funding was from research grants R01DA14028 (STH) and GCRC M01RR109
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Quote: "Randomization was stratified based on the clinic where participants received their pre‐natal care". Participants "were assigned randomly".
Allocation concealment (selection bias) Unclear risk Not stated
Blinding of outcome assessment (detection bias) 
 All outcomes Low risk Abstinence biochemically validated
Incomplete outcome data (attrition bias) 
 All outcomes Low risk Relatively high compliance (83% to 95%) with assessment schedules, and no differences between groups. Withdrawals only for termination or foetal death. 3 intervention and 2 control participants removed from the denominators